caffeic acid and Colorectal Neoplasms

caffeic acid has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chao, CY; Chen, C; Chiang, EI; Kuo, YH; Lin, CC; Pai, MH; Tang, FY	1
Brenner, DE; Chen, D; Fischer, SM; Lee, JJ; Lippman, SM; Lotan, R; Newman, RA; Shureiqi, I; Yang, P	1

Other Studies

2 other study(ies) available for caffeic acid and Colorectal Neoplasms

Article	Year
Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo. PloS one, 2020, Volume: 15, Issue:5 Topics: Animals; Antineoplastic Agents; Autophagy; Caffeic Acids; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclin A; Cyclin E; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Mice; Xenograft Model Antitumor Assays	2020
15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. Journal of the National Cancer Institute, 2000, Jul-19, Volume: 92, Issue:14 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Arachidonate 15-Lipoxygenase; Blotting, Western; Caffeic Acids; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Gas Chromatography-Mass Spectrometry; Gene Expression Regulation, Neoplastic; Humans; Linoleic Acids; Nitrobenzenes; Sulfonamides; Sulindac; Tumor Cells, Cultured; Up-Regulation	2000

Article

Year

Decyl caffeic acid inhibits the proliferation of colorectal cancer cells in an autophagy-dependent manner in vitro and in vivo.

PloS one, 2020, Volume: 15, Issue:5

Topics: Animals; Antineoplastic Agents; Autophagy; Caffeic Acids; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclin A; Cyclin E; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Mice; Xenograft Model Antitumor Assays

2020

15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.

Journal of the National Cancer Institute, 2000, Jul-19, Volume: 92, Issue:14

Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Arachidonate 15-Lipoxygenase; Blotting, Western; Caffeic Acids; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Gas Chromatography-Mass Spectrometry; Gene Expression Regulation, Neoplastic; Humans; Linoleic Acids; Nitrobenzenes; Sulfonamides; Sulindac; Tumor Cells, Cultured; Up-Regulation

2000